Skip to main content

Table 3 Correlations between the changes in study outcomes and changes in EQ-5D index

From: The impact of antihypertensive treatment initiation on health-related quality of life and cardiovascular risk factor levels: a prospective, interventional study

Outcome

r (95% CI)

Crude

Adjusted*

Weight, kg

0.08 (− 0.11 to 0.27)

0.06 (− 0.13 to 0.25)

Waist, cm

 − 0.07 (− 0.25 to 0.13)

 − 0.13 (− 0.32 to 0.06)

Physical activity, FIT index

0.05 (− 0.14 to 0.23)

0.08 (− 0.11 to 0.26)

AUDIT-C score

0.02 (− 0.17 to 0.21)

 − 0.01 (− 0.20 to 0.18)

Total cholesterol, mmol/l

 − 0.05 (− 0.24 to 0.15)

0.01 (− 0.18 to 0.21)

LDL cholesterol, mmol/l

 − 0.05 (− 0.25 to 0.15)

0.01 (− 0.19 to 0.21)

HDL cholesterol, mmol/l

0.10 (− 0.10 to 0.29)

0.16 (− 0.04 to 0.35)

Triglycerides, mmol/l

 − 0.03 (− 0.23 to 0.17)

 − 0.07 (− 0.27 to 0.13)

Fasting glucose, mmol/l

 − 0.09 (− 0.29 to 0.11)

 − 0.12 (− 0.31 to 0.08)

Office BP, mmHg

  

SBP

 − 0.13 (− 0.32 to 0.06)

 − 0.02 (− 0.21 to 0.17)

DBP

 − 0.13 (− 0.31 to 0.06)

 − 0.11 (− 0.29 to 0.08)

  1. *Adjusted for baseline values of EQ-5D, age and sex
  2. AUDIT-C, alcohol consumption questions from the alcohol use disorders identification test (AUDIT); BP, blood pressure; DBP, diastolic blood pressure, EQ-5D, EuroQoL questionnaire of health-related quality of life; FIT index, Frequency-Intensity-Time (FIT) Index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SBP, systolic blood pressure